How RPA is playing a paramount role in reducing R&D costs for the Pharma industry

1. HOW RPA IS PLAYING A PARAMOUNT ROLE IN REDUCING R&D COSTS FOR THE PHARMA INDUSTRY Thankfully, the industry has actively responded to the issue with the emergence of two equally interesting saviors – Robotic Process Automation (RPA) and Business Process Outsourcing. Reducing R&D Costs in Pharma with Robotic Process Automation (RPA) Any high volume process that can be defined with precision and be consistently executed with minimal variation is a prime candidate for Robotic Process Automation. From an economic perspective, reliance on robots is a no-brainer. They boost productivity and reduce spending since they do not require any vacations and if programmed correctly, it can work round the clock without the need to rest. Hence, automating manual tasks with robotic process automation services (RPA) can hugely benefit the Pharma industry by being a game changer. The global pharmaceutical industry involves a quirky inefficiency. Contrary to what one would expect in the R&D process of vital drugs, data handling tasks are mostly manual. The global pharmaceutical industry involves a quirky inefficiency. Contrary to what one would expect in the R&D process of vital drugs, data handling tasks are mostly manual. This traditional approach comes with its fair share of trouble by being prone to human errors. Moreover, increasing regulatory control, the constant need for drug approval, and HR management expenses are making R&D costs shoot right through the roof. This has put the pharma industry in a tough spot and there is an urgent need to contain this rise.